Technology frontiers &
clinical practice
Latest updates from Shanghai HONGYU Medical's R&D center, partner hospitals, and industry conferences.
KAMC conducted the first retrospective study evaluating the association between preoperative NT-proBNP and cTnI Level and clinical outcomes in MMVD dogs undergoing TEER
Since the launch of the V-Clamp procedure, partner centers worldwide have been committed to advancing the successful clinical application of this technique, providing effective treatment for MMVD-affected dogs who are not candidates for open-heart surgery.
HongYu V-Clamp Team Challenged a Short Posterior with Relative Large AP Case
Case Background Recently, the HongYu and XinYu V-Clamp Team received a special patient—Cheese, an 8-year-old female Maltese from Hangzhou, China.
WeHug Team from HongKong Completed V-Clamp Training
Overview WeHug Animal Medical Center from HongKong completed their V-Clamp training this January! WeHUG's predecessor was the Pet Pet Animal Medical Centre located in New Territories, which has been established for over six years.
The First V-Clamp Training Team of 2025
Overview The first V-Clamp Training Team of 2025 consisted of three highly skilled veterinarians from three different regions of Mainland China.
First Team from Belgium - Sanimalia’s Doctors Completed V-Clamp Training
Overview Recently, Sanimalia Veterinary Clinic team from Belgium, the first Belgian V-Clamp training traveled all the way to Shanghai to participate in the V-Clamp training.
The First V-Clamp Case in Malaysia
Case Background On December 8th, 2024, Dr. Anthony Leong and his team successfully completed Malaysia’s first-ever V-Clamp surgery on a MMVD stage B2 patient named Oscar.
Past highlights
¡El Hospital Veterinario Chuan de Taiwán completó su formación en cirugía V-Clamp!
TRAINING PRO｜Formación Avanzada del Equipo del Reino Unido en V-Clamp, ¡48 horas de excelencia!
Reseña de la capacitación en V-Clamp del equipo de cardiología de Shinzo Malasia
Partnership
Collaboration opportunities welcome
For content syndication, co-publishing, or clinical and market collaboration, we welcome further discussion.
Partnership inquiry